Breakthrough treatment for nonalcoholic fatty liver disease Dr. Kamal Kant Kohli Kohli6 Dec 2017 7:28 PM ISTLately improved understanding of the mechanisms behind NAFLD has led to new approaches to pharmacotherapy. This review presents an overview of current...
Canagliflozin lowers risk for heart failure in patients of DM : BMJ Dr. Kamal Kant Kohli Kohli17 March 2018 8:30 PM ISTDr.Elisabetta Patorno and associates conducted a Population-based retrospective cohort study to evaluate the cardiovascular safety of canagliflozin, a...
Diabetes drugs hold potential for treatment of Alzheimer's disease Medha Baranwal Baranwal17 May 2018 7:25 PM ISTA disease mechanism linking Alzheimer's disease and Type 2 diabetes has been discovered by Fernanda De Felice, a professor at Federal University of...
If HbA1c >10,combo of basal insulin and Liraglutide best bet : Study Dr. Kamal Kant Kohli Kohli5 July 2018 8:10 PM ISTInitiating treatment with basal insulin plus the glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide was best for an effective lowering of...
Liraglutide and insulin combo for patients with type 1 diabetes: ADA Medha Baranwal Baranwal17 July 2018 7:25 PM ISTAddition of liraglutide, glucagon-like peptide-1 receptor agonist, to insulin treatment significantly benefits the patients with type 1 diabetes,...
Liraglutide most effective for weight reduction in women with PCOS Medha Baranwal Baranwal9 Aug 2018 8:20 PM ISTLiraglutide appears superior to the other drugs in reducing weight and waist circumference in overweight or obese women with polycystic ovary syndrome...
Semaglutide manages diabetes and weight better than other GLP-1 receptor agonists Medha Baranwal Baranwal18 Aug 2018 8:10 PM ISTSwitching to semaglutide, a GLP-1 analog, from another GLP-1 receptor agonists (such as liraglutide, dulaglutide or exenatide) resulted in a further...
New Therapies for risk reduction in Diabetes with CVD: ACC guidance Medha Baranwal Baranwal29 Nov 2018 7:00 PM ISTThe American College of Cardiology has released new guidance on novel therapies for reduction of cardiovascular (CV) risk in patients with...
GLP-1 receptor agonist not associated with diabetic retinopathy Medha Baranwal Baranwal1 Jan 2019 7:20 PM ISTUSA: An analysis of the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database has revealed that glucagon-like peptide 1...
What is the optimum medical therapy for diabetes management: Status 2019 Medha Baranwal Baranwal18 April 2019 7:03 PM ISTDiabetes in 2019 has been understood as a multi-organ and a multi-specialty disease. It affects the eyes, nerves, kidney, vessels, brain, and heart...
Blood sugar and glycemic control improves in kids by Combo therapy: Ellipse trial Dr. Kamal Kant Kohli Kohli30 April 2019 8:28 PM ISTLiraglutide plus Metformin improve blood sugar and glycemic control in kids.Liraglutide, when added to metformin, is associated with significant...
Adding Liraglutide to metformin offers better blood sugar control in diabetes in children Dr. Kamal Kant Kohli Kohli7 May 2019 7:28 PM ISTLiraglutide addition to metformin effectively controls blood sugar in uncontrolled diabetes in children.Metformin is the regulatory-approved treatment...
